KLRK1 and Kaposi's sarcoma: PGE2 was identified as a critical inhibitory mediator responsible for impairing NK cell response in KS, acting by down-modulation of NKG2D expression on resting NK cells and impairing IL-15 induced proliferation and phenotypic changes [148].